AM-2201
2.6 ★
2.6 ★
222 Ratings
5 ★
0
4 ★
61
3 ★
42
2 ★
56
1 ★
41
(222)
Highlights:
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.[1] It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
$265.00 – $3,200.00